Document source (total no) | Geographic distribution by province (no) | Document types | No identified programme as industry developed | No referenced suboxone independent of programme | Named authorship |
Regulatory bodies (19) | MB, SK (3 ea); AB, NL, PE (2 ea); BC, NB, NS, NT, NU, ON, QC, YT (1 ea) | Information notices (10); Practice guidelines (6); Newsletters (3) | Main text: 2 (10%) References: 1 (5%) | 15 (79%) | 0 (0%) |
Clinical and scientific opinion leaders (18) | ON (6); National (5); BC (4); AB, MB, QC (1 ea) | Professional presentations (10); Clinical Primers (3); Peer-reviewed scientific articles (2); Information sheets (2); Book chapter (1); Policy recommendations (1) | Main text: 2 (11%) References: 1 (6%) | 13 (72%) | 14 (78%) |
Health authorities, professional associations, and educational institutions (28) | ON (8); National (5); BC, NL (4 ea); AB (3); SK (2); QC, YT (1 ea) | Newsletter (6); Info sheet or handbook (6); Programme description (4); Report (3); News notice, news release or programme promotion (3); Proceedings (2); Presentation (1); Meeting minutes (1); Training link (1) | Main text: 3 (11%) References: 0 (0%) | 16 (57%) | 14 (50%) |
Industry (4) | National (2); AB, ON (1 ea) | Posters (2); Publicly available portions of suboxonecme.ca (1); Publicly available programme handbook (1) | Main text: 4 (100%) | N/A | 0 (0%) |
AB, Alberta; BC, British Columbia; MB, Manitoba; NB, New Brunswick; NL, Newfoundland and Labrador; NS, Nova Scotia; NT, Northwest Territories; NU, Nunavut; ON, Ontario; PE, Prince Edward Island; QC, Quebec; SK, Saskatchewan; YT, Yukon.